Fortive Reports Strong Second Quarter 2023 Results; Raises Full Year 2023 Outlook

Q2 revenue of $1.53 billion, up 4.3% with core growth of 5.5% reflecting strong contributions from all segments

Operating margin up 320 basis points to 19%; Record adjusted operating margin of 26%, up 190 basis points

Q2 GAAP EPS of $0.59, up 23%; Adjusted EPS of $0.85, up 9%

Raises 2023 outlook: GAAP EPS of $2.38-$2.44, up 13%-16%; Adjusted EPS of $3.36-$3.42, up 7%-9%

EVERETT, Wash.–(BUSINESS WIRE)–Fortive Corporation (“Fortive”) (NYSE: FTV) today announced financial results for the second quarter 2023.


For the second quarter, net earnings were $209 million. For the same period, adjusted net earnings were $303 million. Diluted net earnings per share for the second quarter was $0.59. For the same period, adjusted diluted net earnings per share was $0.85.

For the second quarter, revenues increased 4.3% year-over-year to $1.53 billion, which included core revenue growth of 5.5%.

James A. Lico, President and Chief Executive Officer, stated, “Our second quarter results once again demonstrated the quality of our portfolio and strength of our execution, yielding 5.5% core growth and record margins in the second quarter driven by strength in Precision Technologies, coupled with recovery in healthcare and momentum in our software and services businesses. Our continued success builds on our culture of continuous improvement and dedication to FBS, which is enabling our teams to relentlessly execute for customers and drive outperformance for Fortive.”

For the third quarter of 2023, Fortive anticipates revenue of approximately $1.5 billion, diluted net earnings per share of $0.59 to $0.62 and adjusted diluted net earnings per share of $0.82 to $0.85.

For the full year 2023, Fortive anticipates revenue of approximately $6.1 billion, diluted net earnings per share of $2.38 to $2.44, and adjusted diluted net earnings per share of $3.36 to $3.42.

Mr. Lico continued, “Our leading positions in customers’ critical connected workflows are benefiting from strong, multi-year secular growth trends, which coupled with the progression to more recurring revenue, is enabling more durable core growth through-cycle. Our differentiated culture and operational capability is expected to continue to yield strong incremental margins, powering our value creation flywheel and allowing Fortive to target mid-teens compounded earnings and free cash flow growth for years to come.”

CONFERENCE CALL DETAILS

Fortive will discuss results and outlook during its quarterly investor conference call today starting at 12:00 p.m. ET. The call and an accompanying slide presentation will be webcast on the “Investors” section of Fortive’s website, www.fortive.com, under “Events & Presentations.” A replay of the webcast will be available at the same location shortly after the conclusion of the presentation.

The conference call can be accessed by dialing 888-440-6928 within the U.S. or by dialing 646-960-0328 outside the U.S. a few minutes before 12:00 p.m. ET and notifying the operator that you are dialing in for Fortive’s earnings conference call (access code 6922572). A digital recording of the conference call will be available two hours after the completion of the call until Wednesday, August 9, 2023. Once available, you can access the conference call replay by dialing 800-770-2030 within the U.S. or 647-362-9199 outside the U.S. (access code 6922572) or visit the “Investors” section of the website under “Events & Presentations.”

ABOUT FORTIVE

Fortive is a provider of essential technologies for connected workflow solutions across a range of attractive end-markets. Fortive’s strategic segments – Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions – include well-known brands with leading positions in their markets. The company’s businesses design, develop, service, manufacture, and market professional and engineered products, software, and services, building upon leading brand names, innovative technologies, and significant market positions. Fortive is headquartered in Everett, Washington and employs a team of more than 18,000 research and development, manufacturing, sales, distribution, service and administrative employees in more than 50 countries around the world. With a culture rooted in continuous improvement, the core of our company’s operating model is the Fortive Business System. For more information please visit: www.fortive.com.

NON-GAAP FINANCIAL MEASURES

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), this earnings release also references “adjusted net earnings,” “adjusted diluted net earnings per share,” “adjusted operating profit margin,” “free cash flow,” and “core revenue growth,” which are non-GAAP financial measures. The reasons why we believe these measures, when used in conjunction with the GAAP financial measures, provide useful information to investors, how management uses such non-GAAP financial measures, a reconciliation of these measures to the most directly comparable GAAP measures and other information relating to these measures are included in the supplemental reconciliation schedule attached. The non-GAAP financial measures should not be considered in isolation or as a substitute for the GAAP financial measures, but should instead be read in conjunction with the GAAP financial measures. The non-GAAP financial measures used by Fortive in this release may be different from similarly-titled non-GAAP measures used by other companies.

FORWARD-LOOKING STATEMENTS

Statements in this release that are not strictly historical, including statements regarding anticipated financial results, business and acquisition opportunities, economic conditions, industry trends, future prospects, shareholder value, and any other statements identified by their use of words like “anticipate,” “expect,” “believe,” “outlook,” “guidance,” or “will” or other words of similar meaning are “forward-looking” statements within the meaning of the federal securities laws. These factors include, among other things: deterioration of or instability in the economy, the markets we serve, international trade policies, the condition of the financial markets and the banking systems, the spread of, and the future resurgence of COVID-19, our ability to adjust purchases, supply chain management, and manufacturing capacity to reflect market conditions and customer demand, reliance on sole sources of supply, changes in relations with China, contractions or lower growth rates and cyclicality of markets we serve, competition, changes in industry standards and governmental regulations, our ability to recruit and retain key employees, our ability to successfully identify, consummate, integrate and realize the anticipated value of appropriate acquisitions and successfully complete divestitures and other dispositions, our ability to develop and successfully market new products, software, and services and expand into new markets, the potential for improper conduct by our employees, agents or business partners, contingent liabilities relating to acquisitions and divestitures, impact of changes to tax laws, our compliance with applicable laws and regulations and changes in applicable laws and regulations, risks relating to international economic, geopolitical, including war and sanctions, legal, compliance and business factors, risks relating to potential impairment of goodwill and other intangible assets, currency exchange rates, tax audits and changes in our tax rate and income tax liabilities, the impact of our debt obligations, including our cost of debt, on our operations, litigation and other contingent liabilities including intellectual property and environmental, health and safety matters, our ability to adequately protect our intellectual property rights, risks relating to product, service or software defects, product liability and recalls, risks relating to product manufacturing, our relationships with and the performance of our channel partners, commodity costs and surcharges, security breaches or other disruptions of our information technology systems, adverse effects of restructuring activities, risk related to tax treatment of the separation of Vontier, impact of our indemnification obligation to Vontier, impact of changes to U.S. GAAP, labor matters, and disruptions relating to man-made and natural disasters and climate change. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our Annual Report on Form 10-K for the year ended December 31, 2022. These forward-looking statements speak only as of the date of this release, and Fortive does not assume any obligation to update or revise any forward-looking statement, whether as a result of new information, future events and developments or otherwise.

FORTIVE CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED STATEMENTS OF EARNINGS

($ and shares in millions, except per share amounts)

(unaudited)

 

 

Three Months Ended

Six Months Ended

 

June 30, 2023

July 1, 2022

June 30, 2023

July 1, 2022

Sales

 

1,526.4

 

 

1,463.3

 

 

2,987.1

 

 

2,839.8

 

Cost of sales

 

(621.0

)

 

(629.8

)

 

(1,233.5

)

 

(1,214.3

)

Gross profit

 

905.4

 

 

833.5

 

 

1,753.6

 

 

1,625.5

 

Operating costs:

 

 

 

 

Selling, general and administrative expenses

 

(514.0

)

 

(484.9

)

 

(1,021.7

)

 

(965.5

)

Research and development expenses

 

(100.1

)

 

(100.1

)

 

(200.2

)

 

(199.2

)

Russia exit and wind down costs

 

 

 

(16.2

)

 

 

 

(16.2

)

Operating profit

 

291.3

 

 

232.3

 

 

531.7

 

 

444.6

 

Non-operating income (expense), net:

 

 

 

 

Interest expense, net

 

(33.1

)

 

(21.0

)

 

(65.2

)

 

(39.8

)

Other non-operating expense, net

 

(7.8

)

 

(3.1

)

 

(10.3

)

 

(5.8

)

Earnings before income taxes

 

250.4

 

 

208.2

 

 

456.2

 

 

399.0

 

Income taxes

 

(41.4

)

 

(35.2

)

 

(73.6

)

 

(60.9

)

Net earnings

$

209.0

 

$

173.0

 

$

382.6

 

$

338.1

 

 

 

 

 

 

Net earnings per share:

 

 

 

 

Basic

$

0.59

 

$

0.48

 

$

1.08

 

$

0.94

 

Diluted

$

0.59

 

$

0.48

 

$

1.07

 

$

0.93

 

Average common stock and common equivalent shares outstanding:

 

 

 

 

Basic

 

353.0

 

 

357.4

 

 

353.3

 

 

358.3

 

Diluted

 

355.5

 

 

359.8

 

 

356.0

 

 

364.2

 

 

This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).

FORTIVE CORPORATION AND SUBSIDIARIES

SEGMENT INFORMATION

($ in millions)

(unaudited)

 

 

Three Months Ended

Six Months Ended

 

June 30, 2023

July 1, 2022

June 30, 2023

July 1, 2022

Sales:

 

 

 

 

Intelligent Operating Solutions

$

653.1

 

$

630.1

 

$

1,285.2

 

$

1,217.7

 

Precision Technologies

 

537.4

 

 

499.1

 

 

1,052.9

 

 

961.5

 

Advanced Healthcare Solutions

 

335.9

 

 

334.1

 

 

649.0

 

 

660.6

 

Total

$

1,526.4

 

$

1,463.3

 

$

2,987.1

 

$

2,839.8

 

 

 

 

 

 

Operating Profit:

 

 

 

 

Intelligent Operating Solutions

$

161.7

 

$

129.9

 

$

295.2

 

$

236.9

 

Precision Technologies

 

136.3

 

 

115.3

 

 

259.0

 

 

216.7

 

Advanced Healthcare Solutions

 

25.9

 

 

28.1

 

 

42.2

 

 

56.1

 

Other (a)

 

(32.6

)

 

(24.8

)

 

(64.7

)

 

(48.9

)

Russia exit and wind down costs

 

 

 

(16.2

)

 

 

 

(16.2

)

Total

$

291.3

 

$

232.3

 

$

531.7

 

$

444.6

 

 

 

 

 

 

Operating Margins:

 

 

 

 

Intelligent Operating Solutions

 

24.8

%

 

20.6

%

 

23.0

%

 

19.5

%

Precision Technologies

 

25.4

%

 

23.1

%

 

24.6

%

 

22.5

%

Advanced Healthcare Solutions

 

7.7

%

 

8.4

%

 

6.5

%

 

8.5

%

Total

 

19.1

%

 

15.9

%

 

17.8

%

 

15.7

%

 

 

 

 

 

(a) Operating profit amounts in the Other category consist of unallocated corporate costs and other costs not considered part of our evaluation of reportable segment operating performance.

This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).

FORTIVE CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED BALANCE SHEETS

($ and shares in millions, except per share amounts)

 

 

As of

 

June 30, 2023

December 31, 2022

 

(unaudited)

 

ASSETS

 

 

Current assets:

 

 

Cash and equivalents

$

712.8

 

$

709.2

 

Trade accounts receivable less allowance for doubtful accounts of $40.4 at June 30, 2023 and $43.9 at December 31, 2022

 

935.2

 

 

958.5

 

Inventories:

 

 

Finished goods

 

231.2

 

 

215.3

 

Work in process

 

105.2

 

 

96.4

 

Raw materials

 

224.8

 

 

225.0

 

Inventories

 

561.2

 

 

536.7

 

Prepaid expenses and other current assets

 

265.4

 

 

272.6

 

Total current assets

 

2,474.6

 

 

2,477.0

 

 

 

 

Property, plant and equipment, net of accumulated depreciation of $789.2 at June 30, 2023 and $754.5 at December 31, 2022

 

425.9

 

 

421.9

 

Other assets

 

474.3

 

 

455.8

 

Goodwill

 

9,051.9

 

 

9,048.5

 

Other intangible assets, net

 

3,304.0

 

 

3,487.4

 

Total assets

$

15,730.7

 

$

15,890.6

 

 

 

 

LIABILITIES AND EQUITY

 

 

Current liabilities:

 

 

Current portion of long-term debt

$

999.9

 

$

999.7

 

Trade accounts payable

 

585.6

 

 

623.0

 

Accrued expenses and other current liabilities

 

999.5

 

 

1,104.4

 

Total current liabilities

 

2,585.0

 

 

2,727.1

 

 

 

 

Other long-term liabilities

 

1,195.7

 

 

1,223.3

 

Long-term debt

 

1,978.2

 

 

2,251.6

 

Commitments and Contingencies (Note 8)

 

 

 

 

 

Equity:

 

 

Common stock: $0.01 par value, 2.0 billion shares authorized; 362.7 million issued and 351.9 million outstanding at June 30, 2023; 361.5 million issued and 352.9 million outstanding at December 31, 2022

 

3.6

 

 

3.6

 

Additional paid-in capital

 

3,778.7

 

 

3,706.3

 

Treasury shares, at cost

 

(572.0

)

 

(442.9

)

Retained earnings

 

7,075.4

 

 

6,742.1

 

Accumulated other comprehensive loss

 

(319.9

)

 

(325.7

)

Total Fortive stockholders’ equity

 

9,965.8

 

 

9,683.4

 

Noncontrolling interests

 

6.0

 

 

5.2

 

Total stockholders’ equity

 

9,971.8

 

 

9,688.6

 

Total liabilities and equity

$

15,730.7

 

$

15,890.6

 

This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).

FORTIVE CORPORATION AND SUBSIDIARIES

CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS

($ in millions)

(unaudited)

 

 

Six Months Ended

 

June 30, 2023

July 1, 2022

Cash flows from operating activities:

 

 

Net earnings

$

382.6

 

$

338.1

 

Noncash items:

 

 

Amortization

 

184.2

 

 

192.1

 

Depreciation

 

42.1

 

 

41.9

 

Stock-based compensation expense

 

55.7

 

 

45.0

 

Russia exit and wind down costs

 

 

 

9.2

 

Change in trade accounts receivable, net

 

26.0

 

 

(37.7

)

Change in inventories

 

(27.4

)

 

(50.7

)

Change in trade accounts payable

 

(36.4

)

 

40.1

 

Change in prepaid expenses and other assets

 

(13.1

)

 

(39.2

)

Change in accrued expenses and other liabilities

 

(118.3

)

 

(29.6

)

Net cash provided by operating activities

 

495.4

 

 

509.2

 

 

 

 

Cash flows from investing activities:

 

 

Payments for additions to property, plant and equipment

 

(45.8

)

 

(37.1

)

Proceeds from sale of property

 

4.9

 

 

 

Cash paid for acquisitions, net of cash received

 

 

 

(1.6

)

Net cash used in investing activities

 

(40.9

)

 

(38.7

)

 

 

 

Cash flows from financing activities:

 

 

Net proceeds from (repayments of) commercial paper borrowings

 

(268.6

)

 

481.3

 

Proceeds from borrowings (maturities greater than 90 days), net of issuance costs

 

 

 

397.0

 

Payment of 0.875% convertible senior notes due 2022

 

 

 

(1,156.5

)

Repurchase of common shares

 

(129.1

)

 

(242.9

)

Payment of dividends

 

(49.3

)

 

(50.0

)

All other financing activities

 

5.6

 

 

(11.8

)

Net cash used in financing activities

 

(441.4

)

 

(582.9

)

 

 

 

Effect of exchange rate changes on cash and equivalents

 

(9.5

)

 

(24.0

)

Net change in cash and equivalents

 

3.6

 

 

(136.4

)

Beginning balance of cash and equivalents

 

709.2

 

 

819.3

 

Ending balance of cash and equivalents

$

712.8

 

$

682.9

 

This information is presented for reference only. A complete copy of Fortive’s Form 10-Q financial statements is available on the Company’s website (www.fortive.com).

FORTIVE CORPORATION AND SUBSIDIARIES

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

AND OTHER INFORMATION

Management believes that each of the non-GAAP financial measures described below provide useful information to investors by reflecting additional ways of viewing aspects of our operations that, when reconciled to the corresponding GAAP measure, help our investors to understand the long-term profitability trends of our business, and facilitate comparisons of our operational performance and profitability to prior and future periods and to our peers.

These non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measures, and may not be comparable to similarly titled measures reported by other companies.

Adjusted Net Earnings, Adjusted Diluted Net Earnings per Share, and Adjusted Operating Profit Margin

We disclose the non-GAAP measures of historical adjusted net earnings, historical and forecasted adjusted diluted net earnings per share and historical adjusted operating profit margin, which to the extent applicable, make the following adjustments to GAAP net earnings, GAAP diluted net earnings per share, and GAAP operating profit margin:

Excluding on a pretax basis amortization of acquisition related intangible assets and non-cash impairments;

Excluding on a pretax basis acquisition and divestiture related items;

Excluding on a pretax basis the costs incurred pursuant to discrete restructuring plans that are fundamentally different from ongoing productivity improvements in terms of the size, strategic nature, planning requirements and the inconsistent frequency of such plans as well as the associated macroeconomic drivers which underlie such plans (the “Discrete Restructuring Charges”); and

Excluding on a pretax basis Russia exit and wind down costs.

In addition, with respect to the non-GAAP measures of historical adjusted net earnings and historical and forecasted adjusted diluted net earnings per share, we make the following adjustments to GAAP net earnings and GAAP diluted net earnings per share:

Excluding on a pretax basis the effect of gains and losses from our equity investments;

Excluding the tax effect (to the extent tax deductible) of the pretax adjustments noted above. The tax effect of such adjustments was calculated by applying our overall estimated effective tax rate to the pretax amount of each adjustment (unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment). We expect to apply our overall estimated effective tax rate to each adjustment going forward; and

Including the actual cash interest expense on our 0.875% Convertible Senior Notes due 2022 (“Convertible Notes”) that was not included under the if-converted methodology mandated in 2022 and, with respect to the adjusted diluted net earnings per share, excluding the outstanding shares of common stock imputed under the in-converted methodology for the Convertible Notes that, in fact, were repaid and settled without issuance of any shares of common stock. Since we settled the Convertible Notes in cash on February 15, 2022 and no common share conversion occurred, we have reversed the impacts of applying the if-converted method and included the actual cash interest expense in calculating the adjusted net earnings per share.

Amortization of Acquisition Related Intangible Assets and Non-cash Impairments

As a result of our acquisition activity, we have significant amortization expense associated with definite-lived intangible assets. We adjust for amortization expense of acquisition related intangible assets incurred in each period, and impairment charges incurred, if any. During the three and six month periods ended June 30, 2023 we recognized $2.9 million related to impairment charges. We believe that this adjustment provides our investors with additional insight into our operational performance and profitability as such impacts are not related to our core business performance.

Acquisition and Divestiture Related Items

While we have a history of acquisition and divestiture activity, we do not acquire and divest businesses or assets on a predictable cycle. The amount of an acquisition’s purchase price allocated to inventory fair value adjustments are unique to each acquisition and can vary significantly from acquisition to acquisition. In addition, transaction costs, which include acquisition, divestiture, integration and restructuring costs related to completed or announced transactions, and the non-recurring gains on divestitures of businesses or assets are unique to each transaction and are impacted from period to period depending on the number of acquisitions or divestitures evaluated, pending, or completed during such period, and the complexity of such transactions.

We adjust for transaction costs, acquisition related fair value adjustments to inventory, integration costs and corresponding restructuring charges primarily related to acquisitions, in each case, incurred in a given period. We believe, however, that it is important for investors to understand that such inventory fair value adjustments related to past acquisitions will recur in future periods until such inventory fair value adjustments, as applicable, have been fully amortized.

Discrete Restructuring Costs

We will exclude costs incurred pursuant to discrete restructuring plans that are fundamentally different in terms of the size, strategic nature and planning requirements, as well as the inconsistent frequency, of such plans originating from significant macroeconomic trends or material disruptions to operations, economy or capital markets from the ongoing productivity improvements that result from application of the Fortive Business System or from execution of general cost saving strategies. Because these restructuring plans will be incremental to the fundamental activities that arise in the ordinary course of our business and we believe are not indicative of our ongoing operating costs in a given period, we exclude these costs to facilitate a more consistent comparison of operating results over time. Restructuring costs related primarily to an acquisition are not included in this adjustment but are instead included in acquisition and divestiture related items.

Russia Ukraine Conflict

In connection with the invasion of Ukraine by Russian forces, the Company exited business operations in Russia in the second quarter of 2022, other than for ASP’s sterilization products, which are exempt from international sanctions as humanitarian products. Our business in Russia and Ukraine accounted for less than 1.0% of total revenue and less than 0.2% of total assets for the fiscal year ended December 31, 2021.

As a result of the exit of our business operations in Russia, the Company recorded a pre-tax charge totaling $16.2 million in the second quarter of 2022 to reflect the write-off of net assets, the write-off of the cumulative translation adjustment in earnings for legal entities deemed substantially liquidated, and to record provisions for employee severance and legal contingencies. These costs are identified as the “Russia exit and wind down costs” in the Consolidated Condensed Statements of Earnings. We adjust for the non-recurring Russia exit and wind down costs because we believe that this adjustment facilitates comparison of our performance with prior and future periods and provides our investors with additional insight into our operational performance.

Gains and Losses from Equity Investments

We adjust for the effect of earnings and losses from our equity method investments over which we do not exercise control over the operations or the resulting earnings or losses.

Contacts

Elena Rosman

Investor Relations

Fortive Corporation

6920 Seaway Boulevard

Everett, WA 98203

Telephone: (425) 446-5000

Read full story here

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.